BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 15078924)

  • 1. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
    J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW; Custer DM; Thompson E
    Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
    Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
    J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit recombinant vaccine protects against monkeypox.
    Heraud JM; Edghill-Smith Y; Ayala V; Kalisz I; Parrino J; Kalyanaraman VS; Manischewitz J; King LR; Hryniewicz A; Trindade CJ; Hassett M; Tsai WP; Venzon D; Nalca A; Vaccari M; Silvera P; Bray M; Graham BS; Golding H; Hooper JW; Franchini G
    J Immunol; 2006 Aug; 177(4):2552-64. PubMed ID: 16888017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
    Saijo M; Ami Y; Suzaki Y; Nagata N; Iwata N; Hasegawa H; Ogata M; Fukushi S; Mizutani T; Sata T; Kurata T; Kurane I; Morikawa S
    J Virol; 2006 Jun; 80(11):5179-88. PubMed ID: 16698998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y; Bray M; Whitehouse CA; Miller D; Mucker E; Manischewitz J; King LR; Robert-Guroff M; Hryniewicz A; Venzon D; Meseda C; Weir J; Nalca A; Livingston V; Wells J; Lewis MG; Huggins J; Zwiers SH; Golding H; Franchini G
    J Infect Dis; 2005 Feb; 191(3):372-81. PubMed ID: 15633096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
    J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against the highly pathogenic VV
    Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
    Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
    Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
    J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodefense. Smallpox vaccines: looking beyond the next generation.
    Enserink M
    Science; 2004 May; 304(5672):809. PubMed ID: 15131277
    [No Abstract]   [Full Text] [Related]  

  • 16. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.
    Hirao LA; Draghia-Akli R; Prigge JT; Yang M; Satishchandran A; Wu L; Hammarlund E; Khan AS; Babas T; Rhodes L; Silvera P; Slifka M; Sardesai NY; Weiner DB
    J Infect Dis; 2011 Jan; 203(1):95-102. PubMed ID: 21148501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW; Golden JW; Ferro AM; King AD
    Vaccine; 2007 Feb; 25(10):1814-23. PubMed ID: 17240007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.
    Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI
    Vaccine; 2009 Dec; 28(2):494-511. PubMed ID: 19833247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
    Edghill-Smith Y; Golding H; Manischewitz J; King LR; Scott D; Bray M; Nalca A; Hooper JW; Whitehouse CA; Schmitz JE; Reimann KA; Franchini G
    Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
    Buchman GW; Cohen ME; Xiao Y; Richardson-Harman N; Silvera P; DeTolla LJ; Davis HL; Eisenberg RJ; Cohen GH; Isaacs SN
    Vaccine; 2010 Sep; 28(40):6627-36. PubMed ID: 20659519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.